BACKGROUND: Historically, studies of adherence to airway clearance therapy in cystic fibrosis (CF) have relied on self-reporting. We compared self-reported airway clearance therapy adherence to actual usage data from home high-frequency chest wall compressions (HFCWC) vests and identified factors associated with overestimation of adherence in self-reports. METHODS: Pediatric patients who perform airway clearance therapy with a HFCWC vest were eligible to participate. Objective adherence data were obtained from the HFCWC device, which records cumulative utilization time. Two readings at least 5 weeks apart were collected. Objective adherence was recorded as a ratio of mean-to-prescribed daily use (%). Self-reported adherence data were collected with a caregiver survey at enrollment. Adherence rates were categorized as low (< 35% of prescribed), moderate (36-79% of prescribed), and high (≥ 80% of prescribed). An overestimation was present when self-reported adherence was at least one category higher than objective adherence. RESULTS: In the final sample (N = 110), mean adherence by usage data was 61%. Only 35% of subjects (n = 38) were highly adherent, and 28% (n = 31) were low adherent. In contrast, 65% of subjects (n = 72) reported high adherence and only 8% (n = 9) reported low adherence (P < .001). Nearly half of self-reports (46%) overestimated adherence. In a multiple regression analysis, overestimation was associated with multiple airway clearance therapy locations (odds ratio 7.13, 95% CI 1.16-43.72, P = .034) and prescribed daily use ≥ 60 min (odds ratio 3.85, 95% CI 1.08-13.76, P < .038). Among subjects with prescribed daily airway clearance therapy ≥ 60 min, the odds of overestimating adherence increased 3-fold (odds ratio 3.04, 95% CI 1.17-7.87, P = .02) in a lower-income (< $50,000/y) environment. CONCLUSIONS: Self-reports overestimated actual adherence to airway clearance therapy, and the overestimation increased with treatment occurring in multiple households and prescribed therapy duration. Among participants with prescribed airway clearance therapy ≥ 60 min, overestimation increased with lower income. Objective measures of adherence are needed, particularly for lower-income children and those receiving treatments in multiple locations.

Children's Hospital of Alabama Birmingham Alabama

Department of Sociology University of Alabama at Birmingham and Research Center for Toxic Compounds in the Environment Masaryk University Czech Republic

Division of Pediatric Pulmonary and Sleep Medicine as well as the Gregory Fleming James Cystic Fibrosis Research Center University of Alabama at Birmingham Alabama

Division of Pediatric Pulmonary and Sleep Medicine as well as the Gregory Fleming James Cystic Fibrosis Research Center University of Alabama at Birmingham Alabama Departments of Medicine and Cell Developmental and Integrative Biology University of Alabama at Birmingham

000      

00000naa a2200000 a 4500

001      

bmc20006693

003      

CZ-PrNML

005      

20200528090437.0

007      

ta

008      

200511s2019 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.4187/respcare.06436 $2 doi

035    __

$a (PubMed)30538158

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Oates, Gabriela R $u Division of Pediatric Pulmonary and Sleep Medicine, as well as the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Alabama. goates@uab.edu.

245    10

$a Objective Versus Self-Reported Adherence to Airway Clearance Therapy in Cystic Fibrosis / $c GR. Oates, I. Stepanikova, SM. Rowe, S. Gamble, HH. Gutierrez, WT. Harris,

520    9_

$a BACKGROUND: Historically, studies of adherence to airway clearance therapy in cystic fibrosis (CF) have relied on self-reporting. We compared self-reported airway clearance therapy adherence to actual usage data from home high-frequency chest wall compressions (HFCWC) vests and identified factors associated with overestimation of adherence in self-reports. METHODS: Pediatric patients who perform airway clearance therapy with a HFCWC vest were eligible to participate. Objective adherence data were obtained from the HFCWC device, which records cumulative utilization time. Two readings at least 5 weeks apart were collected. Objective adherence was recorded as a ratio of mean-to-prescribed daily use (%). Self-reported adherence data were collected with a caregiver survey at enrollment. Adherence rates were categorized as low (< 35% of prescribed), moderate (36-79% of prescribed), and high (≥ 80% of prescribed). An overestimation was present when self-reported adherence was at least one category higher than objective adherence. RESULTS: In the final sample (N = 110), mean adherence by usage data was 61%. Only 35% of subjects (n = 38) were highly adherent, and 28% (n = 31) were low adherent. In contrast, 65% of subjects (n = 72) reported high adherence and only 8% (n = 9) reported low adherence (P < .001). Nearly half of self-reports (46%) overestimated adherence. In a multiple regression analysis, overestimation was associated with multiple airway clearance therapy locations (odds ratio 7.13, 95% CI 1.16-43.72, P = .034) and prescribed daily use ≥ 60 min (odds ratio 3.85, 95% CI 1.08-13.76, P < .038). Among subjects with prescribed daily airway clearance therapy ≥ 60 min, the odds of overestimating adherence increased 3-fold (odds ratio 3.04, 95% CI 1.17-7.87, P = .02) in a lower-income (< $50,000/y) environment. CONCLUSIONS: Self-reports overestimated actual adherence to airway clearance therapy, and the overestimation increased with treatment occurring in multiple households and prescribed therapy duration. Among participants with prescribed airway clearance therapy ≥ 60 min, overestimation increased with lower income. Objective measures of adherence are needed, particularly for lower-income children and those receiving treatments in multiple locations.

650    _2

$a mladiství $7 D000293

650    _2

$a zajištění dýchacích cest $x přístrojové vybavení $x psychologie $x statistika a číselné údaje $7 D058109

650    _2

$a oscilace hrudní stěny $x přístrojové vybavení $x statistika a číselné údaje $7 D035641

650    _2

$a dítě $7 D002648

650    _2

$a cystická fibróza $x psychologie $x terapie $7 D003550

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a odds ratio $7 D016017

650    _2

$a adherence pacienta $x psychologie $x statistika a číselné údaje $7 D010349

650    _2

$a zpráva o sobě $x statistika a číselné údaje $7 D057566

650    _2

$a časové faktory $7 D013997

655    _2

$a srovnávací studie $7 D003160

655    _2

$a časopisecké články $7 D016428

700    1_

$a Stepanikova, Irena $u Department of Sociology, University of Alabama at Birmingham and Research Center for Toxic Compounds in the Environment (RECETOX), Masaryk University, Czech Republic.

700    1_

$a Rowe, Steven M $u Division of Pediatric Pulmonary and Sleep Medicine, as well as the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Alabama. Departments of Medicine and Cell Developmental and Integrative Biology, University of Alabama at Birmingham.

700    1_

$a Gamble, Stephanie $u Children's Hospital of Alabama, Birmingham, Alabama.

700    1_

$a Gutierrez, Hector H $u Division of Pediatric Pulmonary and Sleep Medicine, as well as the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Alabama.

700    1_

$a Harris, William T $u Division of Pediatric Pulmonary and Sleep Medicine, as well as the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Alabama.

773    0_

$w MED00193500 $t Respiratory care $x 1943-3654 $g Roč. 64, č. 2 (2019), s. 176-181

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30538158 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20200511 $b ABA008

991    __

$a 20200528090434 $b ABA008

999    __

$a ok $b bmc $g 1525551 $s 1096749

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 64 $c 2 $d 176-181 $e 20181211 $i 1943-3654 $m Respiratory care $n Respir Care $x MED00193500

GRA    __

$a P30 DK072482 $p NIDDK NIH HHS $2 United States

LZP    __

$a Pubmed-20200511